1 – 10 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Serum sclerostin levels in men with idiopathic osteoporosis
- Consumption of an olive polyphenolic extract for 12 months prevents bone loss and improves serum lipid profiles in postmenopausal women
- An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®
- 2012
- Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
- Osteoporosis in young adults: pathophysiology, diagnosis, and management
- Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
- A reappraisal of generic bisphosphonates in osteoporosis
- Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
- Frailty and sarcopenia: definitions and outcome parameters
- Vitamin D status and physical activity interact to improve bone mass in adolescents: the HELENA study